🇺🇸 FDA
Patent

US 12351649

Antibodies to oxidation-specific epitopes

granted A61PA61P1/16A61P9/10

Quick answer

US patent 12351649 (Antibodies to oxidation-specific epitopes) held by The Regents of the University of California expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P1/16, A61P9/10